MedTrace Logo

The Effect of Desflurane on Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting

NCT02213718 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-08-11

No results posted yet for this study

Summary

This study is to assess the effect of desflurane on myocardial function in patents who underwent coronary artery bypass grafting.

Conditions

  • Coronary Artery Bypass Graft Redo
  • General Anesthetic Drug Adverse Reaction

Interventions

DRUG

Desflurane

desflurane (7%-8% end-tidal concentration)

DRUG

propofol

propofol (TCI:3.5-4.0μg/min)

DRUG

sufentanil

TCI: 2-3 ng/ml during the duration of surgery, an expected average of 4 hours

Sponsors & Collaborators

  • Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Ailin Luo, Doctor · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-01-31
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213718 on ClinicalTrials.gov